MHMax Hell

Max Hell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Max Hell has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Berend Isermann

    Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig Medical Center, Leipzig, Germany

    1 shared publication
  • Madlen Reinicke

    Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics (S.S., S.A., S.J., M.R., Z.L., R.R., A.E., B.I., U.C., M.L.H.), University Leipzig Medical Center, Germany

    1 shared publication
  • Mitja L. Heinemann

    Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics (S.S., S.A., S.J., M.R., Z.L., R.R., A.E., B.I., U.C., M.L.H.), University Leipzig Medical Center, Germany

    1 shared publication
  • Saikal Shamkeeva

    Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Leipzig University Hospital, 04103 Leipzig, Germany

    1 shared publication
  • Uta Ceglarek

    Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig , Leipzig

    1 shared publication

Latest Publications

  • Open Access

    Targeted Lipidomics for Characterization of PUFAs and Eicosanoids in Extracellular Vesicles

    by Madlen Reinicke, Saikal Shamkeeva, Max Hell, Berend Isermann, Uta Ceglarek, Mitja L. Heinemann

    Lipids are increasingly recognized as bioactive mediators of extracellular vesicle (EV) functions. However, while EV proteins and nucleic acids are well described, EV lipids are insufficiently understood due to lack of adequate quantitative methods. We adapted an established targeted and quantitative mass spectrometry (LC-MS/MS) method originally developed for analysis of 94 eicosanoids and seven polyunsaturated fatty acids (PUFA) in human plasma. Additionally, the influence of freeze–thaw (FT) cycles, injection volume, and extraction solvent were investigated. The modified protocol was applied to lipidomic analysis of differently polarized macrophage-derived EVs. We successfully quantified three PUFAs and eight eicosanoids within EVs. Lipid extraction showed reproducible PUFA and eicosanoid patterns. We found a particularly high impact of FT cycles on EV lipid profiles, with significant reductions of up to 70%. Thus, repeated FT will markedly influence analytical results and may alter EV functions, emphasizing the importance of a standardized sample pretreatment protocol for the analysis of bioactive lipids in EVs. EV lipid profiles differed largely depending on the polarization of the originating macrophages. Particularly, we observed major changes in the arachidonic acid pathway. We emphasize the importance of a standardized sample pretreatment protocol for the analysis of bioactive lipids in EVs.